Jaguar Health Directors Dash Into Own Shares, Betting Big on a Comeback Amid 95% Stock Slide
Jaguar Health insider buying signals confidence amid volatility, with top execs and directors buying 80,000+ shares as the company pushes its plant‑derived GI portfolio forward.
3 minutes to read

